Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer.

Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer.
复制标题

结构提出了一种将弱自肽肿瘤抗原转化为癌症中 CD8 T 细胞超级激动剂的方法

DOI:
10.1073/pnas.2100588118
复制
发表时间:
2021-06-08
影响因子:
11.1
通讯作者:
Yin L
Yin L
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Wei P;Jordan KR;Buhrman JD;Lei J;Deng H;Marrack P;Dai S;Kappler JW;Slansky JE;Yin L

文献摘要

参考文献

相似文献

使用修饰的自身抗原的肿瘤疫苗在结构上增强了 T 细胞受体-肽-主要组织相容性复合物的相互作用,大大提高了 T 细胞针对肿瘤未修饰的自身抗原的保护反应。这些相互作用的 X 射线晶体结构解释了天然肽和修饰肽如何与相同的 T 细胞受体相互作用,但具有不同的亲和力和驱动 T 细胞增殖和分化的能力。肿瘤经常表达未突变的自身肿瘤相关抗原(自身TAA)。然而,使用自体 TAA 作为癌症疫苗靶点的试验结果好坏参半,这通常归因于 T 细胞在 T 细胞发育过程中删除了具有自体 TAA 高亲和力受体 (TCR) 的 T 细胞。突变这些弱的自身 TAA 以产生更高亲和力的有效疫苗具有挑战性,因为突变可能不会使广泛的自身 TAA 特异性 T 细胞库的所有成员受益。我们之前发现了一种常见的弱鼠自体TAA,我们通过单个氨基酸替换将其转化为高效的抗肿瘤疫苗。在这种情况下,修饰的和天然的自体 TAA 仍然产生非常相似的 CD8 T 细胞组。我们的结构研究表明,自身 TAA 的修饰导致主要组织相容性复合物 I-TAA 结构发生微妙的变化。这种氨基酸取代使得肽在随后的 TCR 结合过程中发生了巨大的构象变化,从而大大增加了 TCR 亲和力,并解释了修饰的自 TAA 作为疫苗的功效。这些结果表明,对免疫原性较差的自身 TAA 进行精心选择、充分表征的修饰可以挽救大量弱反应的天然自身 TAA 特异性 CD8 T 细胞的免疫反应,驱使它们增殖并分化为功能性效应细胞。随后,肿瘤细胞上未经修饰的自 TAA 虽然无法驱动这种反应,但仍然是 CD8 细胞毒性效应器的足够目标。我们的结果提出了一种更有效地识别常见自体 TAA 变体的途径,这可能有助于疫苗开发,补充当前其他非抗原特异性免疫疗法。
Tumor vaccines using modified self-antigens that structurally enhance T cell receptor–peptide–major histocompatibility complex interactions greatly improve a T cell protective response against the tumor’s unmodified self-antigen. X-ray crystal structures of these interactions explain how the native and modified peptides can interact with the same T cell receptor, but with different affinities and abilities to drive T cell proliferation and differentiation. Tumors frequently express unmutated self-tumor–associated antigens (self-TAAs). However, trial results using self-TAAs as vaccine targets against cancer are mixed, often attributed to deletion of T cells with high-affinity receptors (TCRs) for self-TAAs during T cell development. Mutating these weak self-TAAs to produce higher affinity, effective vaccines is challenging, since the mutations may not benefit all members of the broad self-TAA–specific T cell repertoire. We previously identified a common weak murine self-TAA that we converted to a highly effective antitumor vaccine by a single amino acid substitution. In this case the modified and natural self-TAAs still raised very similar sets of CD8 T cells. Our structural studies herein show that the modification of the self-TAA resulted in a subtle change in the major histocompatibility complex I–TAA structure. This amino acid substitution allowed a dramatic conformational change in the peptide during subsequent TCR engagement, creating a large increase in TCR affinity and accounting for the efficacy of the modified self-TAA as a vaccine. These results show that carefully selected, well-characterized modifications to a poorly immunogenic self-TAA can rescue the immune response of the large repertoire of weakly responding natural self-TAA–specific CD8 T cells, driving them to proliferate and differentiate into functional effectors. Subsequently, the unmodified self-TAA on the tumor cells, while unable to drive this response, is nevertheless a sufficient target for the CD8 cytotoxic effectors. Our results suggest a pathway for more efficiently identifying variants of common self-TAAs, which could be useful in vaccine development, complementing other current nonantigen-specific immunotherapies.
DOI: 10.1016/j.immuni.2011.09.013
发表时间: 2011-11-23
期刊: Immunity
影响因子: 32.4
作者:
Adams JJ;Narayanan S;Liu B;Birnbaum ME;Kruse AC;Bowerman NA;Chen W;Levin AM;Connolly JM;Zhu C;Kranz DM;Garcia KC
通讯作者: Garcia KC
DOI: 10.3389/fimmu.2018.01499
发表时间: 2018
影响因子: 7.3
作者:
Guo Y;Lei K;Tang L
通讯作者: Tang L
在肿瘤浸润淋巴细胞上表达的孤儿T细胞受体的抗原鉴定。
DOI: 10.1016/j.cell.2017.11.043
发表时间: 2018-01-25
期刊: Cell
影响因子: 64.5
作者:
Gee MH;Han A;Lofgren SM;Beausang JF;Mendoza JL;Birnbaum ME;Bethune MT;Fischer S;Yang X;Gomez-Eerland R;Bingham DB;Sibener LV;Fernandes RA;Velasco A;Baltimore D;Schumacher TN;Khatri P;Quake SR;Davis MM;Garcia KC
通讯作者: Garcia KC
DOI: 10.1084/jem.176.6.1681
发表时间: 1992-12-01
期刊: The Journal of experimental medicine
影响因子: --
作者:
Corr M;Boyd LF;Frankel SR;Kozlowski S;Padlan EA;Margulies DH
通讯作者: Margulies DH
DOI: 10.1107/s0907444904019158
发表时间: 2004-12-01
影响因子: 2.2
作者:
Emsley, P;Cowtan, K
通讯作者: Cowtan, K